Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sands China Ltd. Director's Dealing 2021

Apr 19, 2021

50273_rns_2021-04-19_ab8fff65-8e44-495a-a354-af1c2e67d469.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [72 x 43] intentionally omitted <==

Zhong Ji Longevity Science Group Limited 中基長壽科學集團有限公司

(formerly known as ASIA PACIFIC SILK ROAD INVESTMENT COMPANY LIMITED 亞太絲路投資有限公司 )

(Incorporated in Bermuda with limited liability)

(Stock Code: 767)

VOLUNTARY ANNOUNCEMENT

ACQUISITION OF SHARES BY THE CHAIRMAN FROM A SUBSTANTIAL SHAREHOLDER

This announcement is made by Zhong Ji Longevity Science Group Limited (the ‘‘Company’’) on a voluntary basis.

The board (the ‘‘Board’’) of directors (the ‘‘Director(s)’’) of the Company was notified by Mr. Yan Li (‘‘Mr. Yan’’), the chairman of the Board (the ‘‘Chairman’’) and an executive Director, that on 19 April 2021, Mr. Yan acquired 184,030,000 ordinary shares of the Company (the ‘‘Share(s)’’) from Hong Kong Financial Services Asset Management L.P., a substantial shareholder of the Company, at a total consideration of approximately HK$97,535,900, representing HK$0.53 per Share (the ‘‘Acquisition’’).

Immediately following the Acquisition, Mr. Yan will hold 184,030,000 Shares, representing approximately 4.76% of the total issued share capital of the Company as at the date of this announcement. He will also hold, through Zhong Ji 1 International Medical Group (Hong Kong) Limited, convertible notes issued by the Company with a principal amount of HK$1,840,000,000, the conversion rights of which, if exercised in full at a conversion price of HK$0.2, are convertible into 9,200,000,000 Shares of the

– 1 –

Company; and Hong Kong Financial Services Asset Management L.P. will hold 969,503,068 Shares, representing approximately 25.05% of the total issued share capital of the Company as at the date of this announcement.

By order of the Board Zhong Ji Longevity Science Group Limited Yan Li Chairman

Hong Kong, 19 April 2021

As at the date of this announcement, the Directors are:

Executive Directors Independent non-executive Directors Mr. Yan Li (Chairman) Ms. Ho Man Wai Mr. Yeung Siu Keung Ms. Wang Weixia Ms. Cao Xie Qiong Mr. Mak Ping Leung (alias: Mr. Mak Wah Cheung) Non-executive Directors Mr. To Langa Samuelson Ms. Yu Yang Ms. Choi Ngai Wah

In the case of any inconsistency, the English text of this announcement shall prevail over the Chinese text.

– 2 –